Article

Cardiovascular Medications Not Prescribed Equally Among Men and Women Study Says

Some cardiovascular medications are prescribed to women less often than men according to a study published today in the Journal of the American Heart Association.

Some cardiovascular medications are prescribed to women less often than men according to a study published today in the Journal of the American Heart Association.

Previous research found that female hearty attack survivors were less likely to be given prescriptions for recommended medications then their male counterparts in the hospital.  This metanalysis examines whether preventative medications such as statins, aspirin, ACE inhibitors and diuretics are prescribed equally across the genders prior to heart attack.

The results showed that women received:
• 19% fewer aspirin prescriptions than men;
• 10% fewer statin prescriptions than men; and
• 15% fewer ACE-inhibitor prescriptions than men. 
• 27% more prescriptions for diuretics.

"Additional efforts need to be taken to ensure that everyone, women and men, who should receive cardiovascular medications are actually prescribed these medications," said lead study author Sanne Peters, Ph.D., research fellow in epidemiology at the George Institute for Global Health at the University of Oxford in the United Kingdom and associate professor at the University Medical Center Utrecht in the Netherlands. "We also need to reduce the persistent treatment gaps between women and men."

Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
© 2024 MJH Life Sciences

All rights reserved.